✦ LIBER ✦

Long-term application of disease modifying antirheumatic drugs (DMARD). A single-center, observational study of 1681 patients with rheumatoid arthritis (RA)

✍ Scribed by M. Keysser; G. Keyßer; C. Keysser

Book ID: 113038910
Publisher: Springer-Verlag
Year: 1999
Tongue: German
Weight: 141 KB
Volume: 58
Category: Article
ISSN: 0340-1855
DOI: 10.1007/s003930050181

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

RESEARCH: Effects of Long-Term Disease-M

RESEARCH: Effects of Long-Term Disease-Modifying Antirheumatic Drugs on Endothelial Function in Patients with Early Rheumatoid Arthritis

✍ M. Turiel; L. Tomasoni; S. Sitia; S. Cicala; L. Gianturco; C. Ricci; F. Atzeni; 📂 Article 📅 2010 🏛 Hindawi Limited 🌐 English ⚖ 612 KB

Efficacy of tocilizumab in patients with

Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study

✍ Yazici, Y.; Curtis, J. R.; Ince, A.; Baraf, H.; Malamet, R. L.; Teng, L. L.; Kav 📂 Article 📅 2011 🏛 BMJ Publishing Group 🌐 English ⚖ 301 KB

Early combination disease-modifying anti

Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial

✍ Vappu Rantalaiho, Markku Korpela, Leena Laasonen… 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 857 KB

Phase IIb dose-ranging study of the oral

Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs

✍ Roy Fleischmann; Maurizio Cutolo; Mark C. Genovese; Eun Bong Lee; Keith S. Kanik 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 4 views

Tocilizumab in Patients With Active Rheu

Tocilizumab in Patients With Active Rheumatoid Arthritis and Inadequate Response to Disease-modifying Antirheumatic Drugs or Tumor Necrosis Factor Inhibitors: Subanalysis of Spanish Results of an Open-label Study Close to Clinical Practice

✍ Álvaro-Gracia, José M.; Fernández-Nebro, Antonio; García-López, Alicia; Guzmán, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 Spanish ⚖ 544 KB